MRNS Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders.

$10.77  +0.71 (7.06%)
As of 12/07/2021 13:37:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/31/2014
Outstanding shares:  36,766,355
Average volume:  143,029
Market cap:   $342,294,765
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    56854Q200
ISIN:        US56854Q2003
Sedol:      BM8MVZ3
Valuation   (See tab for details)
PE ratio:   -4.21
PB ratio:   4.98
PS ratio:   22.27
Return on equity:   -112.03%
Net income %:   -572.08%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy